Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-25.58	20.63	27.72
Graham Fair Price	114.77	3491.29	1625.62
PEG	-96.54	0.02	-0.52
Price/Book	5.47	0.83	0.79
Price/Cash Flow	inf	0.00	12.27
Prices/Earnings	-77.16	6.47	28.34
Price/Sales	-11.27	1.85	2.08
Price/FCF	inf	0.00	12.27
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	13.26	0.17	0.15
Operating Margin	43.35	0.08	0.05
ROA	371.41	0.01	< 0.005
ROE	< 0.005	0.03	361.78
ROIC	< 0.005	0.01	138.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.01	0.08	-82.53
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.10	0.73	642.10
EPS QOQ	-0.55	3.62	560.28
FCF QOQ	0.04	-1.00	2203.10
Revenue QOQ	0.01	0.21	1804.75
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.07	19.66	-36.72
Days Sales Outstanding (DSO)	58.96	55.62	-5.65
Inventory Turnover	2.90	4.58	58.04
Debt/Capitalization	0.44	0.44	-0.20
Quick Ratio	0.92	1.25	35.69
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4112.44	4110.06	-0.06
Cash	586.90	882.11	50.30
Capex	0.00	0.00	0.00
Free Cash Flow	263.81	0.00	inf
Revenue	1554.59	1846.64	18.79
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.50	1.95	29.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.57	8.47	-32.61
Naive Interpretation	Member

06 - Financial Health · Weak

Rating